There is a version of fund launches that follows a predictable script. A press release, a target raise, a strategy description that sounds like every other strategy description, a quote from the managing partner about being excited to deploy capital into a dynamic sector at an inflection point.
This is not that.
What we are announcing is something we have spent considerable time building the foundations for before committing to a public structure. The strategy is live. The first positions are identified. The thesis is tested against real deals, real companies, and real land. We are publishing this because we believe transparency about how we think is more valuable than a polished fundraising narrative, and because the people who should find this interesting will find it through the thinking, not through the announcement.
The structure
Hive’s evergreen investment strategy is a EUR 100 million vehicle domiciled in Luxembourg and listed on the Vienna Stock Exchange.
The Vienna Stock Exchange listing is not incidental. It provides a mechanism for secondary liquidity in a vehicle that is otherwise designed for long-duration holding. Investors who need to exit can do so through the secondary market without forcing the fund to liquidate positions. The underlying portfolio can remain invested for as long as the economics of each business warrant, independent of any individual investor’s liquidity needs. This resolves one of the structural tensions that has historically made evergreen private market vehicles difficult to distribute: the mismatch between patient capital deployment and investor liquidity expectations.
Luxembourg domicile was chosen for regulatory depth, cross-border distribution access, and the established infrastructure for alternative fund management. The combination of a Luxembourg-domiciled vehicle with Vienna Stock Exchange listing and AIFMD-compliant management structure is deliberate. It creates a vehicle that is accessible to European institutional investors, family offices, and qualified retail investors through a single share class on a regulated market, without the closed-ended fund constraints that would force exits on a fixed schedule.
What we invest in
The strategy focuses on the full value chain of essential industries. Food systems, agriculture, biotechnology, industrial processing, water, and circular economy infrastructure. Not as a thematic checklist, but as an integrated thesis about where durable economic value is created in the real economy.
Full value chain means we do not restrict ourselves to one layer. A food innovation campus that upscales biotech ingredients from lab to industrial production sits alongside a consumer food brand that puts those ingredients on shelves, alongside a circular supply chain platform that recovers the waste coming out of that production process. These are not three unrelated investments. They are three positions in a connected system, each reinforcing the others, each benefiting from the same underlying market dynamic: Europe’s food and agricultural system is restructuring, and the capital flowing into that restructuring has not yet found its natural home.
The geographic focus is Europe, with a current emphasis on Central Eastern Europe. This is not a developing market bet. It is a timing bet. Farmland in western Hungary trades at a fraction of comparable Austrian land, not because the soil is different but because foreign ownership restrictions have structurally suppressed demand. EU funds that were politically frozen for sixteen years are beginning to move. A new government has reset Hungary’s relationship with Brussels. The capital that is about to flow into rural land and agricultural infrastructure in that region will do so on top of positions we are already building. We intend to be early rather than to arrive when the opportunity is already priced.
The investment criteria
Every position in the portfolio is evaluated against a set of criteria that are deliberately simple and deliberately strict.
Target companies must be revenue generating. We do not invest in pre-revenue concepts, regardless of how compelling the technology or the team. The evidence we need to underwrite an investment cannot come from projections alone. It must come from real customers who have paid real money for a product or service and returned to do so again.
Target companies must demonstrate a minimum annual growth potential of 15%. This is not a target we set for them. It is a threshold that must already be visible in the underlying economics before we commit capital. We are looking for businesses where the constraint on growth is capital and distribution, not product-market fit. The tipping point we invest at is the moment when the evidence is sufficient to be confident about the trajectory, but the market has not yet priced that trajectory into the entry valuation.
Each position is evaluated with an initial three to five year growth horizon. The evergreen structure means we are not forced to exit at the end of that window. If a business is still compounding well at year five, we hold it. If the right exit opportunity arrives at year three, we take it. The decision is made by the economics of the business, not the structure of the fund.
We target approximately 15% compound portfolio growth per year, across a concentrated set of positions. Conviction investing means fewer bets made with higher confidence, rather than diversification for its own sake. We would rather hold eight positions we understand deeply than twenty positions we monitor from a distance.
The venture building dimension
One element of the Hive strategy that does not fit neatly into standard fund descriptions is the role of proprietary asset ownership in originating deal flow.
The GP holds significant agricultural land positions in Central Eastern Europe, along with an existing network of operating businesses, local relationships, and regional infrastructure in that corridor. This is not a fund asset. It is the GP’s own balance sheet, built over years of presence in the region.
What it creates, practically, is a pipeline of venture building opportunities that no purely financial competitor can replicate. Businesses originated from owned land, where the GP controls the underlying physical asset and has the relationships to assemble the operating team, the local licences, the supply chain access, and the regulatory positioning that external investors would spend years trying to build independently. Agricultural operations, hospitality, agritourism, wineries, processing facilities: each of these is a business that can be built on a land platform, brought to commercial traction, and evaluated for fund investment at the tipping point where external capital accelerates what is already working.
The fund does not own the land. The GP does. But the land creates the origination engine that distinguishes Hive’s deal flow from a fund that sources purely from the open market.
This is a structure with precedent. Family office platforms with operating asset bases have long used proprietary infrastructure to seed businesses before bringing in institutional co-investors. What is less common is a GP with this kind of regional operating depth who has also built an institutional evergreen vehicle to deploy alongside it. The combination is the edge.
The Thesis, directly stated
Most impact funds pick a layer of the value chain and stay there. Most land funds buy land and wait. Most venture builders focus on technology because technology does not require physical assets to get started. Most evergreen funds are recent innovations in institutional packaging rather than genuine expressions of a long-duration investment philosophy.
Hive is trying to be something different from all of those, and the differentiation is structural rather than rhetorical.
Patient capital, deployed at the commercial tipping point, across the full value chain of essential European industries, originating proprietary deal flow from owned physical assets, in a listed evergreen structure that removes forced-exit pressure and provides secondary liquidity without portfolio disruption.
The sectors we focus on are not exciting in the way that AI or fintech is exciting. Food production is not a sector that generates breathless coverage. Agricultural land in Central Eastern Europe does not appear on the cover of technology magazines. Industrial processing infrastructure is not a dinner party conversation.
But food is consumed every day by every person on earth. Agricultural land is finite and appreciating. Industrial processing is the bottleneck that determines whether food innovation ever reaches a plate. And the companies solving real problems in these industries, at real scale, with real customers, are generating the kind of durable compounding returns that patient capital was designed to capture.
Summary
EUR 100 million evergreen strategy, listed on the Vienna Stock Exchange, domiciled in Luxembourg. Focused on food systems, agriculture, biotechnology, water, circular economy, and industrial processing. Full value chain approach. Minimum 15% annual growth threshold for target companies. Revenue generating businesses only, invested at the tipping point of commercial scaling. Approximately 15% compound portfolio growth target. Evergreen structure enabling long-term compounding and flexible exits.
For further information: wr@crqs.capital
